ANDOVER, Mass., Dec. 18, 2023 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the upcoming 42nd Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 8, 2024, at 3:00 p.m. Pacific Standard Time / 6:00 p.m. Eastern Standard Time.
Event: 42nd Annual J.P. Morgan Healthcare Conference
Date: Monday, January 8, 2024
Time: 3:00 p.m. PST
A live and archived webcast of the presentation will be available on the “Investors” section of the TransMedics website at https://investors.transmedics.com/.
About TransMedics Group, Inc.
TransMedics is the world’s leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.
Investor Contact:
Brian Johnston
332-895-3222
[email protected]
SOURCE TransMedics Group, Inc.
Originally published at https://www.prnewswire.com/news-releases/transmedics-to-participate-in-the-42nd-annual-jp-morgan-healthcare-conference-302018201.html
Images courtesy of https://pixabay.com
